¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"gene rearrangement, b-lymphocyte, light chain"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® light reflex ÇÑ±Û ºû¹Ý»ç
¼³¸í   
  1. ÇÑÂÊ ´«¿¡ ºûÀ» ºñÃ߸é, ÀÌ ºûÀº ½Ã°¢½Å°æ¿¡ ÀÇÇØ ³ú¿¡ Àü´ÞµÇ°í, ÀÌ ÀÚ±ØÀº »ç¶÷ÀÇ ÀÇÁö¿Í ¹«°üÇϰԠ°ð, ´«µ¹¸²½Å°æÀ¸·Î Àü´ÞµÇ¾î ¾çÂÊ ´«ÀÇ µ¿°øÀÌ Ãà¼ÒÇϰԠµÈ´Ù. ÀÌ·± ¸ðµç ÀÏ·ÃÀÇ °úÁ¤À» ºû¹Ý»ç¶ó ºÎ¸£´Âµ¥ À̰ÍÀº »ç¶÷ÀÌ ¾îµÎ¿î °÷¿¡ °¡°Å³ª ¾îµÎ¿î °÷¿¡¼­ °©Àڱ⠹àÀº °÷¿¡ ³ª°¬À» ¶§, µ¿°øÀÌ ¹Ý»çÀûÀ¸·Î ¿òÁ÷À̴ °Í°ú °°Àº °ÍÀÌ´Ù. 2. °í¸·¿¡¼­ ¹Ý»çÇϴ ±¤»ó. 3. ¸Á¸·°æÀÇ °Å¿ï·Î ¸Á¸·¿¡¼­ ¹Ý»çÇϴ °í¸®¸ð¾çÀÇ ¸¹Àº Á¡.
¿µ¹® gene ÇÑ±Û À¯ÀüÀÚ
¼³¸í   
  À¯ÀüÀڴ ±æ°Ô ¶ì¸¦ Çü¼ºÇÑ DNAºÐÀÚÀÇ ÀϺκÐÀ¸·Î ÇÑ °¡Áö ¹°ÁúÀ» ¸¸µå´Âµ¥ ÇÊ¿äÇÑ ¸ðµç Á¤º¸¸¦ °®Ãá ±â´ÉÀûÀΠ´ÜÀ§ÀÌ´Ù. ¿¹¸¦ µé¾î Àν¶¸°À̶ó´Â ¹°ÁúÀÇ À¯ÀüÀÚ¶ó°í Çϸ頻ç¶÷ÀÇ ¼¼Æ÷³»¿¡ Àִ ±ä DNA ºÐÀÚ Áß¿¡¼­ Àν¶¸°À̶ó´Â ¹°ÁúÀ» ¸¸µå´Âµ¥ ÇÊ¿äÇÑ ¸ðµç Á¤º¸¸¦ °¡Áö°í Àִ ÇÑ ºÎºÐÀ» °¡¸®Å°´Â ¸»ÀÌ´Ù. °íÀüÀûÀΠ»ý¹°Çп¡¼­´Â À¯ÀüÀÚ°¡ Ç¥ÇöÇüÀ» °áÁ¤Çϰųª ÁöÁ¤Çϴ ¿°»öüÀÇ ÀϺκÐÀ̶ó°í Á¤ÀǵǾúÁö¸¸, ¿À´Ã³¯¿¡´Â À¯ÀüÀÚ¿¡ ´ëÇØ¼­ ºÐÀÚÀû Á¤Àǰ¡ Á¦¾ÈµÇ°í ÀÖÀ¸¸ç ±× Á¤ÀǴ ÇϳªÀÇ À¯ÀüÀڴ ÇϳªÀÇ È¿¼Ò¸¦ °áÁ¤ ¶Ç´Â ¾ÏȣȭÇϴ À¯Àü¹°ÁúÀÇ ÀϺκÐÀ̶ó´Â °³³äÀ¸·Î À̰ÍÀÌ À̸¥¹Ù 1°³ÀÇ À¯ÀüÀÚ 1°³ È¿¼Ò°¡¼³(one gene-one enzyme hypothesis)ÀÌ´Ù. Áï 1°³ÀÇ À¯ÀüÀڴ 1°³ÀÇ È¿¼Ò¸¦ Á¦ÀÛÇϴµ¥ ÇÊ¿äÇÑ À¯ÀüÁ¤º¸¸¦ °¡Áø´Ù´Â °ÍÀÌ´Ù. ÇöÀç ÀÌ °¡¼³ÀÌ ¹Þ¾Æµé¿©Áö°í ÀÖ´Ù.
¿µ¹® gene therapy ÇÑ±Û À¯ÀüÀÚ¿ä¹ý
¼³¸í   
  À¯Àüº´À» Ä¡·áÇÒ ¸ñÀûÀ¸·Î, Á¤»óÀûÀ¸·Î ±â´ÉÇϴ ´ÜÀÏÀ¯ÀüÀڠȤÀº º¹¼öÀ¯ÀüÀÚ¸¦ ¾î¶² ±â¿ø¿¡¼­ ¾ò¾î³»¾î »ý¼¼Æ÷¿¡ µµÀÔÇϴ °Í. À¯Àü¹°ÁúÀº À¯ÀüÀÚ»ðÀÔ Á¶ÀÛ¿¡ ÀÇÇØ ¼ö¿ë¼¼Æ÷¿¡·Î µµÀԵȴÙ. Áï, À¯ÀüÀÚ¸¦ ³¢¿ö ³ÖÀº »õ·Î¿î ¼¼Æ÷¸¦ »ç¿ëÇϴ ġ·á·Î¼­ 1980³â ¹Ì±¹ÀÇ ÇÐÀÚ°¡ ÁöÁßÇØºóÇ÷ȯÀÚ¿¡°Ô °­ÇàÇÏ¿© ºñÆÇÀ» ¹Þ¾ÒÁö¸¸, ¹Ì±¹ ±¹¸³º¸°Ç¿¬±¸¼Ò´Â 1990³â 9¿ù ¾Æµ¥³ë½Å µ¥¾Æ¹Ì³ª¾ÆÁ¦(adenosine deaminase, ADA) °áÇÌÁõ È¯ÀÚÀÇ ¸²ÇÁ±¸¿¡ ADA À¯ÀüÀÚ¸¦ ³¢¿ö ³Ö´Â Ä¡·á¸¦ ½ÃÀÛÇÑ ÀÌ·¡ ÇöÀç´Â ¾ÏÀ» Æ÷ÇÔÇÑ ¸¹Àº Áúº´µéÀ» Ä¡·áÇϴ ¸ñÀûÀ¸·Î ¾²ÀδÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • light chain
    °¡º­¿î»ç½½, °æ¼â
  • light chain disease
    °¡º­¿î»ç½½º´, °æ¼âº´
  • light-chain nephropathy
    °¡º­¿î»ç½½ÄáÆÏº´(Áõ), °æ¼â½ÅÀ庴(Áõ)
  • chromosomal rearrangement
    ¿°»öüÀç¹è¿­
  • rearrangement
    Àç¹è¿­
  • closed chain
    ´ÝÈù»ç½½
  • closed-chain compound
    ´ÝÈù»ç½½È­ÇÕ¹°
  • cold chain
    Àú¿ÂÀ¯Áö¸Á
  • chain
    »ç½½, ¿¬¼â
  • chain compound
    »ç½½È­ÇÕ¹°
  • chain cystourethrography
    »ç½½¹æ±¤¿äµµÁ¶¿µ(¼ú)
  • chain fiber
    Çٻ罽¼¶À¯, Çٻ罽±ÙÀ°¼¼Æ÷
  • chain initiation reaction
    ¿¬¼â°³½Ã¹ÝÀÀ
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • chain saw
    »ç½½Åé
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • light chain
    °¡º­¿î»ç½½, °æ¼â
  • rearrangement
    Àç¹è¿­
  • light
    ºû, ±¤, ±¤¼±
  • reflected light
    ¹Ý»ç±¤
  • chain
    »ç½½
  • respiratory chain
    È£Èí»ç½½
  • side chain
    °ç»ç½½
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ, ÁßÇÕ¿¬¼â¹ÝÀÀ
  • gene
    À¯ÀüÀÚ
  • allelic gene
    ´ë¸³À¯ÀüÀÚ
  • regulator gene
    Á¶ÀýÀ¯ÀüÀÚ
  • structural gene
    ±¸Á¶À¯ÀüÀÚ
  • suicide gene
    ÀÚ»ìÀ¯ÀüÀÚ
  • supressor gene
    ¾ïÁ¦À¯ÀüÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • light chain
    °¡º­¿î»ç½½, °æ¼â
  • light-chain nephropathy
    °¡º­¿î»ç½½ÄáÆÏº´Áõ
  • chromosomal rearrangement
    ¿°»öüÀç¹è¿­
  • rearrangement
    Àç¹è¿­
  • chain
    »ç½½
  • chain compound
    »ç½½È­ÇÕ¹°
  • chain cystourethrography
    »ç½½¹æ±¤¿äµµÁ¶¿µ¼ú
  • chain fiber
    (¢¡nuclear chain fiber) Çٻ罽¼¶À¯, Çٻ罽±ÙÀ°¼¼Æ÷
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • chain saw
    »ç½½Åé
  • chain structure
    »ç½½±¸Á¶, ¿¬¼â±¸Á¶
  • chain initiation reaction
    ¿¬¼â°³½Ã¹ÝÀÀ
  • chain termination method
    ¿¬¼âÁ¾·á¹ý
  • chromosome chain
    ¿°»öü»ç½½, ¿°»öü°í¸®
  • closed chain
    ´ÝÈù»ç½½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • D-JH rearrangement
    D-JH Àç¹è¿­
  • LASER (light amplification by stimulated emission of
    radiation) ·¹ÀÌÀú
  • LP=>light perception
    ºû´À³¦, ±¤°¢
  • Light adaptation
    ¸í¼øÀÀ(Ù¥â÷ëë)
  • Light reflex
    ´ë±¤¹Ý»ç(ÓÛÎÃÚãÞÒ)
  • Woods light
    ¿ìµåÁ¶¸í.
  • Woods light
    ¿ìµåÁ¶¸í
  • incident light
    ÀԻ籤¼±(í¡ÞÒÎÃàÊ).
  • infrared light
    Àû¿Ü¼±µî
  • infrared light
    Àû¿Ü¼±
  • persistent light reaction
    Áö¼Ó¼º ±¤¹ÝÀÀ
  • polarization of light
    Æí±¤(ø¶ÎÃ).
  • polarized light microscopy
    Æí±¤Çö¹Ì°æ
  • polymorphous light eruption
    ´ÙÇü±¤¼±ÇÇÁø
  • polymorphous light eruption
    ´ÙÇü±¤¼±ÇÇÁø(Òýû¡ÎÃàÊù«òÖ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chain, light
    °æ¼â, °æ»ç½½, L¼â
  • light chain
    °æ¼â
  • light chain
    °æ¼â(Ìîáð).
  • light-chain nephropathy
    °æ¼â ½ÅÁõ(Ìã ãìñø)
  • bcr-abl rearrangement
    bcr-ablÀç¹è¿­
  • chromosomal rearrangement
    ¿°»öüÀç¹è¿­
  • chromosome(s),rearrangement
    Àç¹è¿­ (î¢ÛÕÖª)
  • molecular rearrangement
    ºÐÀÚÀç¹è¿­.
  • rearrangement
    Àç¹è¿­
  • axial light
    Ã౤
  • black light
    Èæ»ö±¤¼±
  • central light
    Á߽ɱ¤, Ã౤
  • coherent light
    Áý¼ÓÆòÇ౤
  • cold light
    ³Ã±¤(ËÄË´).
  • cone of light
    ±¤Ãß(¸é)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Nuclear chain fiber
    Çٻ罽±ÙÀ°¼¼Æ÷
    [¿¾ ¿ë¾î] ÇÙ¼â
  • Light cell
    ¹àÀº¼¼Æ÷
    [¿¾ ¿ë¾î] ¸í¼¼Æ÷
  • Light cell
    ¹àÀº¼¼Æ÷
    [¿¾ ¿ë¾î] ¸íÁÖ¼¼Æ÷
  • Mutant gene
    µ¹¿¬º¯ÀÌÀ¯ÀüÀÚ
    [¿¾ ¿ë¾î] [µ¹¿¬]º¯ÀÌÀ¯ÀüÀÚ
  • Autosomal gene
    º¸Åë¿°»öüÀ¯ÀüÀÚ
    [¿¾ ¿ë¾î] »ó¿°»öüÀ¯ÀüÀÚ
  • Gonosomal gene
    ¼º¿°»öüÀ¯ÀüÀÚ
    [¿¾ ¿ë¾î] ¼º¿°»öüÀ¯ÀüÀÚ
  • Recessive autosomal gene
    ¿­¼ºº¸Åë¿°»öüÀ¯ÀüÀÚ
    [¿¾ ¿ë¾î] ¿­¼º»ó¿°»öüÀ¯ÀüÀÚ
  • Recessive gonosomal gene
    ¿­¼º¼º¿°»öüÀ¯ÀüÀÚ
    [¿¾ ¿ë¾î] ¿­¼º¼º¿°»öüÀ¯ÀüÀÚ
  • Dominant autosomal gene
    ¿ì¼ºº¸Åë¿°»öüÀ¯ÀüÀÚ
    [¿¾ ¿ë¾î] ¿ì¼º»ó¿°»öüÀ¯ÀüÀÚ
  • Dominant gonosomal gene
    ¿ì¼º¼º¿°»öüÀ¯ÀüÀÚ
    [¿¾ ¿ë¾î] ¿ì¼º¼º¿°»öüÀ¯ÀüÀÚ
  • Lethal gene
    Ä¡»çÀ¯ÀüÀÚ
    [¿¾ ¿ë¾î] Ä¡»çÀ¯ÀüÀÚ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chromosome rearrangement
    ¿°»öü Àç¹è¿­(æøßäô÷î¢ÛÕæï)
  • rearrangement reaction
    Àç¹è¿­ ¹ÝÀÀ(î¢ÛÕÖªÚãëë)
  • light chain
    °æ(Ìî)»ç½½
  • one-gene-one-polypeptide chain hypothesis
    ÀÏÀ¯ÀüÀÚ(ìéë¶îîí­) ÀÏ(ìé)Æú¸®ÆéŸÀÌµå »ç½½¼³(àã)
  • circularly polarized light
    ¿øÆí±¤(ê­ø¶ÎÃ)
  • light chopper
    ±¤(ÎÃ)ÃÊÆÛ
  • light compensation point
    ±¤ º¸»óÁ¡(ÎÃÜÍßÁïÃ)
  • light-harvesting Chl a/b protein
    Áý±¤¼º¿±·Ïü(ó¢ÎÃàõç¨Öàô÷) a/b ´Ü¹éÁú(Ó±ÛÜòõ)
  • light-harvesting molecule
    Áý±¤ºÐÀÚ(ó¢ÎÃÝÂí­)
  • light isotope
    °æµ¿À§¿ø¼Ò(ÌîÔÒêÈêªáÈ)
  • light label
    °æÇ¥Áö(Ìîøúò½)
  • light meromyosin
    °æ(Ìî) ¸Þ·Î¸¶ÀÌ¿À½Å
  • light microscope
    ±¤ÇÐÇö¹Ì°æ(ÎÃùÊúéÚ°Ìð)
  • light path
    ±¤·Î(ÎÃÖØ)
  • light reaction
    ±¤¹ÝÀÀ(ÎÃÚãëë)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gene
    À¯ÀüÀÎÀÚ
  • rearrangement
    Àç¹è¿­
  • chain
    ¿¬¼â, ¼â, °í¸®, »ç½½
  • chain cystography
    »ç½½¹æ±¤Á¶¿µ¼ú
  • infrared light
    Àû¿Ü¼±µî
  • laser [=light amplification by stimulated emission of radiation]
    ·¹ÀÌÀú
  • light adaptation
    ¸í¼øÀÀ
  • light amplification by stimulated emission of radiation [=LASER]
    ·¹ÀÌÀú
  • visible light
    °¡½Ã±¤¼±
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
VL variable domain of the light chain; variable light chain
LM lactic acid mineral [medium]; lactose malabsorption; laryngeal mask; laryngeal muscle; lateral malle...
LS lateral suspensor; left sacrum; left septum; left side; legally separated; leiomyosarcoma; length of...
kappa a light chain of human immunoglobulins [chain]
LC Laennec cirrhosis; Langerhans cell; late clamped; large chromophobe; lecithin cholesterol acyltransf...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CCR complex chromosomal rearrangement
L-chain Light-chain
IgL Immunoglobulin light chain
LCDD K-light chain deposition disease
LC3 Light chain 3
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chromosomal rearrangement
    ¿°»öü Àç¹è¿­
  • molecular rearrangement
    ºÐÀÚ Àç¹è¿­
  • rearrangement chromosome
    Àç¹è¿­ ¿°»öü
  • branched chain
    Ãø¼â
  • chain
    ¿¬¼â, ¼â, °í¸®, »ç½½
    ¼±»óÀ¸·Î ´ç°ú ´çÀÌ °áÇÕµÈ ÁýÇÕ¹°. ¿¹ÄÁ´ë È­ÇÕ¹°¿¡ À־ ¿øÀÚ È¤Àº ±âÀÇ ÁýÇÕ, ¶Ç´Â °³°³ ¼¼±ÕÀÌ ¿°ÁÖ ¸ð¾çÀ¸·Î µÈ ¼¼Æ÷ ¸ðÀÓ.
  • chain compound
    »ç½½ È­ÇÕ¹°
  • chain fiber
    ¿¬¼â ¼¶À¯
  • chain initiation reaction
    ¿¬¼â °³½Ã ¹ÝÀÀ
  • chain reflex
    ¿¬¼â ¹Ý»ç
    ÇϳªÀÇ Àڱؿ¡¼­ ´ÙÀ½ÀÇ ÀÚ±ØÀ¸·Î Â÷·Ê·Î ÀüÇØÁ®¼­ ¿ÏÀüÇÑ È°µ¿À¸·Î ³ªÅ¸³ª´Â ÀÏ·ÃÀÇ ¹Ý»ç.
  • chain structure
    ¿¬¼â ±¸Á¶
  • Ehrlich`s side chain theory
    ¿¡¸¦¸®È÷ÀÇ Ãø¼â¼³
    Ç×ü »ý»ê ±âÀü¿¡ ´ëÇÏ¿© Á¦¾ÈµÈ °¡¼³ÀÇ Çϳª. ¸ðµç ü ¼¼Æ÷ Ç¥¸é¿¡´Â Ãø¼â¶ó°í ÇÏ´Â ¼ö¿ëü°¡ ÀÖ°í, À̰Ϳ¡ ´ëÀÀÇÏ´Â Ç׿øÀÌ °áÇÕÇϸé Ȱ¼ºÈ­ µÇ°í, Ãø¼â°¡ °úÀ× »ý»êµÇ¾î Ç×ü·Î¼­ Ç÷·ù ¼Ó¿¡ ¹æÃâµÈ´Ù°í ÇÏ´Â »ý°¢. Ç×ü »ý»êÀÇ ¼±Åü³ÀÇ ÃÖÃÊÀÇ °ÍÀÌ´Ù.
  • H chain
    Áß¼â, Á߻罽, H¼â
  • heavy chain
    H »ç½½, H ¼â, Áß¼â
    1. ¸é¿ª ±Û·ÎºÒ¸°ÀÇ ÇÑ ºÎºÐ. 2. ¸é¿ª ±Û·ÎºÒ¸°À» ±¸¼ºÇϰí ÀÖ´Â µÎ °³ÀÇ ºÐÀÚ¼âÀÇ ºÐÀÚ·®ÀÌ Å« Æú¸®ÆéŸÀ̵带 ¸»ÇÑ´Ù.
  • heavy chain disease
    H ¼âº´, Á߼⺴
    ´ÜŬ·Ð¼ºÀÇ °¨¸¶ ±Û·ÎºÒ¸° ÀÌ»óÀ¸·Î¼­, Ç׿ø¼º °áÁ¤ ÀÎÀÚ°¡ °á¿©µÈ ¸é¿ª ±Û·ÎºÒ¸°ÀÌ »ý»êµÈ´Ù.
  • J chain
    J¼â, J »ç½½, ¿¬°á »ç½½
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
gene rearrangement, b-lymphocyte, light chain Ordered rearrangement of b-lymphocyte variable gene regions coding for the kappa or lambda light chains, thereby contributing to antibody diversity. It occurs during the second stage of differentiation of the immature b-lymphocyte.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
gene rearrangement, alpha-chain T-cell antigen receptor Ordered rearrangement of T-cell variable gene regions coding for the alpha-chain of antigen receptors.
(12 Dec 1998)
gene rearrangement, beta-chain T-cell antigen receptor Ordered rearrangement of T-cell variable gene regions coding for the beta-chain of antigen receptors.
(12 Dec 1998)
gene rearrangement, b-lymphocyte, heavy chain Ordered rearrangement of b-lymphocyte variable gene regions thereby contributing to antibody diversity. It occurs during the first stage of differentiation of the immature b-lymphocyte.
(12 Dec 1998)
gene rearrangement, delta-chain T-cell antigen receptor Ordered rearrangement of T-cell variable gene regions coding for the delta-chain of antigen receptors.
(12 Dec 1998)
gene rearrangement, gamma-chain T-cell antigen receptor Ordered rearrangement of T-cell variable gene regions coding for the gamma-chain of antigen receptors.
(12 Dec 1998)
gene rearrangement A structural alteration of a chromosome that causes a change in the orderof its loci.
(09 Oct 1997)
gene rearrangement, b-lymphocyte Ordered rearrangement of b-lymphocyte variable gene regions coding for the immunoglobulin chains, thereby contributing to antibody diversity. It occurs during the differentiation of the immature b-lymphocyte.
(12 Dec 1998)
gene rearrangement, t-lymphocyte Ordered rearrangement of T-cell variable gene regions coding for the antigen receptors.
(12 Dec 1998)
P light chain <protein> Myosin light chain that can be phosphorylated by myosin light chain kinase, as a result of phosphorylation, the myosin is activated.
(18 Nov 1997)
myosin light chain <protein> The light chains of the muscle protein myosin. Each molecule of myosin is composed of two heavy chains and two pairs of light chains. The light chains have a molecular weight of about 20 kD and there is one dissimilar pair of light chains associated with each heavy chain.
The proteins all have sequence homology to calmodulin, but not all with calcium binding activity.
Several types are known: regulatory light chains (LC 2, DNTB light chains) probably regulate the ATPase activity of the heavy chain directly (through the binding of calcium) or indirectly (activating when they themselves are phosphorylated by myosin light chain kinase) and essential light chains (LC 1, LC 3, alkali light chains), which have a more subtle and apparently nonessential role.
In molluscan muscle the EDTA light chains (similar to LC 2 from vertebrate muscle) confer calcium sensitivity on the myosin itself.
The light chains are "calmodulin-like" proteins that bind calcium. Two of them can be removed easily, and two with difficulty. The light chains bind the heavy chains in the vicinity of the head groups of the myosin.
(12 Dec 1998)
myosin light chain kinase <enzyme> An enzyme that phosphorylates myosin light chains in the presence of ATP to yield myosin-light chain phosphate and ADP, and requires calcium and calmodulin.
The 20-kD light chain is phosphorylated more rapidly than any other acceptor, but light chains from other myosins and myosin itself can act as acceptors. The enzyme plays a central role in the regulation of smooth muscle contraction.
Chemical name: ATP:myosin-light-chain O-phosphotransferase
Registry number: EC 2.7.1.117
(12 Dec 1998)
immunoglobulins, light-chain Polypeptide chains, consisting of 211 to 217 amino acid residues, isolated from immunoglobulins and having a molecular weight of approximately 22 kD. There are two major types of light chains, kappa and lambda. In man they are found in a ratio of 60% to 40%, respectively. Both chains consist of linear repeating, similar, but not identical, segments of about 110 amino acid residues. In each segment a disulfide bond establishes a tightly folded approximately 60-membered loop or domain. Adjacent domains are linked by less tightly folded regions. Both light chains contain two such domains. Two light and two heavy chains make one immunoglobulin molecule, but both light chains in one ig are of the same type.
(12 Dec 1998)
EDTA light chain <protein> Myosin light chains (18 kD) from scallop muscle (two per pair of heavy chains), easily extracted by calcium chelation. Although the EDTA light chains do not bind calcium they confer calcium sensitivity on the myosin heavy chains.
(18 Nov 1997)
light chain <immunology, protein> The lighter of the two types of polypeptide chains that are found in immunoglobulin and antibody molecules.
Also used as a non-specific term for the smaller subunits of several multimeric proteins such as immunoglobulin, myosin, dynein, clathrin.
(14 Oct 1997)
light chain-related amyloidosis A form of primary amyloidosis in which the fibrillar amyloid deposits are derived from the amino terminal variable region of the light chains of immunoglobulin; seen in B-lymphocyte and plasma-cells dyscrasias.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Gene Rearrangement, B-Lymphocyte, Light Chain - »õâ Ordered rearrangement of B-lymphocyte variable gene regions coding for the kappa or lambda light chains, thereby contributing to antibody diversity. It occurs during the second stage of differentiation of the immature B-lymphocyte.
    Synonyms : B Cell Light Chain Gene Rearrangement, B Cell kappa-Chain Gene Rearrangement, B Cell lambda-Chain Gene Rearrangement, B Lymphocyte Light Chain Gene Rearrangement, B Cell kappa Chain Gene Rearrangement, B Cell lambda Chain Gene Rearrangement
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • rearrangement
    Àç¹è¿­
  • light chain
    Àü±â ½ºÅĵåÀÇ ²ö
  • Ir gene
    (»ýÈ­)IrÀ¯ÀüÀÚ(¸é¿ª ÀÀ´ä À¯ÀüÀÚ)
  • coat gene
    ÇǸ·À¯ÀüÀÚ
  • dominant gene
    (»ý)¿ì¼º À¯ÀüÀÚ
  • gene
    À¯Àü(ÀÎ)ÀÚ
  • gene bank
    À¯ÀüÀÚ ÀºÇà(À¯Àü ¹°ÁúÀ» »ýÁ¸½ÃŲ »óÅ·Πº¸Á¸ÇÏ´Â ½Ã¼³
  • gene deletion
    À¯ÀüÀÚ »èÁ¦(ºÒÇÊ¿äÇÑ À¯ÀüÀÚÀÇ Á¦°Å)
  • gene expression
    À¯ÀüÀÚ ¹ßÇö(À¯ÀüÀÚ Á¤º¸°¡ ƯÁ¤ ÇüÁú·Î¼­ ³ªÅ¸³ª±â)
  • gene insertion
    À¯ÀüÀÚ »ðÀÔ(ºüÁ®ÀÖ´Â À¯ÀüÀÚ¸¦ »ðÀÔÇϱâ)
  • gene manipulation
    À¯ÀüÀÚ Á¶ÀÛ(ÀÎÀ§ÀûÀ¸·Î À¯ÀüÀÚ¸¦ ¿Å±â°Å³ª ¿°»öü µîÀ» º¯È­½Ã۱â)
  • gene mapping
    À¯ÀüÀÚ Áöµµ(¿°»öü»óÀÇ À¯ÀüÀÚ ÀÚ¸®¸¦ °áÁ¤Çϱâ)
  • gene pool
    À¯ÀüÀÚ Ç®;À¯ÀüÀÚ °ø±Þ¿ø(¸àµ¨ Áý´ÜÀ» ±¸¼ºÇÏ´Â ¸ðµç °³Ã¼°¡ °¡Áö°í ÀÖ´Â À¯ÀüÀÚ Àüü)
  • gene therapy
    À¯ÀüÀÚ ¿ä¹ý(°á¼ÕµÈ À¯ÀüÀÚ¸¦ º¸ÃæÇÏ¿© À¯Àüº´À» °íÄ¡´Â ¿ä¹ý)
  • nif gene
    (»ýÈ­)Áú¼Ò °íÁ¤¿¡ °ü¿©ÇÏ´Â À¯ÀüÀÚ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á